Posted in | News | Gold | Mining Business

Aton Resources Reports Filing of NI 43-101 Independent Technical Report for Hamama West Deposit

Aton Resources Inc. (TSX VENTURE:AAN) ("Aton" or the "Company") is pleased to announce that it has filed a NI 43-101 independent technical report for the Hamama West Deposit ("Hamama West"), one of three contiguous zones that comprise the Hamama Project ("Hamama" or the "Project"), located within the Company's 100% owned Abu Marawat Concession ("Abu Marawat") in Egypt. Hamama West hosts an Inferred Mineral Resource of 341,000 ounces gold equivalent and an Indicated Mineral Resource of 137,000 ounces AuEq*.

Resources at Hamama West represent only 750 metres of the 3,000-metre-long mineralized horizon at Hamama, which remains open along strike and at depth. A 2,300 metre drill program is currently underway at Hamama West with the goal of increasing potential resources at depth. The Company will provide investors with a more fulsome exploration update within the next week.

About Hamama

Hamama is located at the western end of the 40-km long gold trend at the Abu Marawat concession and is comprised of three zones, Hamama West, Hamama Central and Hamama East. The mineralized horizon at Hamama has a strike length of approximately 3-km and remains open to the east, possibly to the west, and at depth. Mapping indicates that the mineralized horizon may extend another 1.8-kms to the east. Further exploration work will be conducted to confirm this. Other potentially mineralized horizons, separate from the main mineralized horizon, have also been mapped in the general Hamama area.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.